FOXP3 and hepatocellular carcinoma: Furthermore, fewer Tim-3+Foxp3+ CD4 T cells were observed in the tumors of early TNM stage HCC patients, consistent with another report of negligible Tim-3 expression by Foxp3+ TILs isolated from relatively early-stage HCC patients [16].